AI ETFs offer diversified exposure to a booming industry, giving investors a way to navigate September volatility while staying invested in AI's growth.
JPM's Kinexys is gaining traction as blockchain settlement speeds fund transfers and supports deeper client ties and Payments growth.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
The headline numbers for Ollie's Bargain Outlet (OLLI) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
While the top- and bottom-line numbers for Gitlab (GTLB) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Gold continues to be a noisy place to trade, but on Wednesday morning, we have seen the important 200-day EMA act as support, perhaps lending a hand for those that are bullish.
The Canadian dollar has weakened as dollar CAD rebounded more than 1.5% off its monthly low into a pivot zone where three time frames converge. Michael Boutros, StoneX Media Senior Market Analyst, walks through the weekly, daily and four hour structure in dollar CAD and maps the event risk sitting on top of it.
X-Energy is rated a Buy based on its strong management, technology moat, and de-risked commercialization path. XE's Xe-100 reactor leverages TRISO fuel for superior safety, passive shutdown, and rapid construction, reducing capital costs and build times. The company's vertical integration, notably its TRISO-X facility, addresses critical fuel supply bottlenecks and enhances commercialization prospects.
Gold: Data risks and CTA selling – TD Securities
The central bank left its main interest rate unchanged at 2.25%, and said the escalating trade conflict between the U.S. and Canada threatens to add to inflation.
BP, CVX, XOM and TTE are deploying AI to cut downtime, sharpen drilling, improve asset performance and drive more efficient energy operations.
NLST is gaining AI-memory momentum as Lightning DDR5, CXL, MRDIMM and IP initiatives expand its growth potential.
Visa is turning A2A fraud protection into a growth opportunity, using AI to detect scams earlier while opening new software revenue streams.
ENSG's decentralized model is driving organic growth through higher occupancy, stronger clinical results and improved productivity across its facilities.
Dividend investors have many factors to consider when deciding which stocks suit their needs. This includes dividend growth rates, dividend yields, and dividend sustainability—often calculated based on a firm's payout ratio.
Maravai (MRVI) is evolving into an integrated supplier for the in vitro transcription (IVT) RNA workflow, embedding products across the customer lifecycle. Q2 2026 marked a profitability inflection, with gross margins rising to 40.1% and Adjusted EBITDA turning positive, reflecting successful cost realignment and segment-level improvement. TriLink's integrated GMP enzyme facility and ModTail technology strengthen customer stickiness, while Cygnus provides recurring, high-margin biologics safety earnings.
Nexa Resources delivered a robust Q2, with revenue up 28% and EBITDA up 78%, driving a Buy rating at ~$13 per share. Operational catalysts—Aripuanã ramp-up, Cerro Lindo cost reductions, and brownfield exploration—are poised to boost future earnings and cash flow. Valuation remains compelling at 5.1x 2026E and 4.2x 2027E earnings, with a standalone fair value estimated at $18–$24 per share.
AstraZeneca reports positive SANOVO data, showing Tagrisso plus Orpathys improved PFS in first-line EGFR-mutated NSCLC.
Universal Music Group N.V. (UMGNF) is rated a BUY at $16.96, offering compelling long-term value with dominant market share and resilient recurring revenues. Universal Music's scale, catalog depth, and strong bargaining power with streaming platforms underpin its competitive moat and future growth prospects. Recent Downtown Music acquisition temporarily depresses margins but supports strategic industry consolidation and long-term synergy potential.
AST SpaceMobile (NASDAQ:ASTS) stock is up 11% to $62.36 in Wednesday morning trading, its sharpest single-session bid in weeks. Planet Labs (NYSE:PL) stock is climbing alongside, up 5% to $20.14 on the same initiation.